HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vik Khullar Selected Research

Tolterodine Tartrate (Detrol)

1/2018Tolterodine ER reduced increased bladder wall thickness in women with overactive bladder. A randomized, placebo-controlled, double-blind, parallel group study.
1/2012Antimuscarinic effects on current perception threshold: a prospective placebo control study.
4/2010Mixed incontinence: current evidence and future perspectives.
10/2008Urinary incontinence at orgasm: relation to detrusor overactivity and treatment efficacy.
8/2008A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome.
10/2007Treatment outcomes in the STAR study: a subanalysis of solifenacin 5 mg and tolterodine ER 4 mg.
1/2005"Unblinding" in randomized controlled drug trials for urinary incontinence: Implications for assessing outcomes when adverse effects are evident.
8/2004Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
3/2004Mixed incontinence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vik Khullar Research Topics

Disease

35Overactive Urinary Bladder (Overactive Bladder)
01/2018 - 07/2005
12Urinary Incontinence
01/2019 - 07/2004
4Prolapse
05/2021 - 01/2006
4Pain (Aches)
01/2020 - 07/2013
4Stress Urinary Incontinence
01/2019 - 07/2004
4Nocturia
06/2015 - 05/2006
4Constipation
12/2014 - 05/2008
4Urge Urinary Incontinence (Urge Incontinence)
04/2010 - 06/2003
3Lower Urinary Tract Symptoms
01/2020 - 11/2016
3Pelvic Pain
01/2016 - 09/2013
2Interstitial Cystitis (Interstitial Cystitis, Chronic)
01/2020 - 07/2013
2Urinary Tract Infections (Urinary Tract Infection)
03/2017 - 05/2008
2Wounds and Injuries (Trauma)
11/2015 - 01/2006
2Inflammation (Inflammations)
07/2013 - 03/2011
1Dysbiosis
11/2019
1Dyspareunia
01/2019
1Burns
01/2019
1Chronic Pain
01/2019
1Cicatrix (Scar)
01/2019
1Bacteriuria
01/2018
1Fibrosis (Cirrhosis)
03/2017
1Uterine Prolapse (Vaginal Prolapse)
03/2017
1Myalgia
10/2015
1Hyperalgesia
10/2015
1Nocturnal Enuresis (Bedwetting)
06/2015
1Pelvic Floor Disorders
04/2015
1Spasm (Spasms)
09/2013
1Disease Progression
07/2013
1Uterine Hemorrhage (Uterine Bleeding)
06/2003
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
04/2002

Drug/Important Bio-Agent (IBA)

14Muscarinic AntagonistsIBA
06/2015 - 08/2004
9Tolterodine Tartrate (Detrol)FDA Link
01/2018 - 03/2004
9fesoterodineFDA Link
06/2015 - 05/2008
8mirabegronIBA
11/2016 - 01/2012
5Pharmaceutical PreparationsIBA
12/2014 - 01/2005
3Biomarkers (Surrogate Marker)IBA
01/2018 - 03/2011
2CollagenIBA
03/2017 - 01/2006
2Nerve Growth Factor (NGF)IBA
11/2016 - 03/2011
26-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
10/2015 - 09/2013
2Type A Botulinum Toxins (Botox)FDA Link
09/2013 - 08/2013
2CytokinesIBA
08/2012 - 03/2011
2darifenacinFDA Link
12/2011 - 05/2006
2Solifenacin SuccinateFDA Link
08/2008 - 10/2007
1Polytetrafluoroethylene (Teflon)FDA Link
05/2021
1A-factor (Streptomyces)IBA
11/2019
1ElastinIBA
03/2017
1CreatinineIBA
11/2016
1Adrenergic Receptors (Adrenergic Receptor)IBA
11/2016
1Botulinum Toxins (Botulinum Toxin)IBA
01/2016
1P-2 (P 2)IBA
06/2015
1ORALIT (ORS)IBA
04/2015
1Brain-Derived Neurotrophic Factor (BDNF)IBA
07/2013
1Nerve Growth Factors (Neurotrophins)IBA
07/2013
1BXL628IBA
07/2012
1Dinoprostone (PGE2)FDA Link
03/2011
1Estradiol (Delestrogen)FDA LinkGeneric
06/2003
1Clomiphene (Clomifene)FDA LinkGeneric
04/2002

Therapy/Procedure

6Therapeutics
01/2016 - 08/2004
2Suburethral Slings (Tension-Free Vaginal Tape)
01/2019 - 06/2015
2Cesarean Section (Caesarean Section)
11/2015 - 07/2004
2Drug Therapy (Chemotherapy)
12/2014 - 09/2008
1Intravesical Administration
01/2020
1Lasers (Laser)
01/2019
1Bariatric Surgery
01/2019
1Combination Drug Therapy (Combination Chemotherapy)
01/2019
1Length of Stay
03/2017
1Catheters
03/2017
1Incontinence Pads
02/2013
1Denervation
01/2006
1Hysterectomy
06/2003